Ion News and Research

RSS

Agilent Technologies launches industry’s first transportable GC/MS system delivering laboratory-quality analysis

Agilent Technologies Inc. today introduced the 5975T Low Thermal Mass (LTM) Gas Chromatography/Mass Spectrometry Detector (GC/MSD), the industry’s first commercial transportable GC/MS system that delivers laboratory-quality analysis. Using proprietary LTM technology, Agilent has developed the 5975T LTM GC/MS to be smaller, more rugged and to consume less power than in-lab GC/MS instruments, yet capable of the same high-quality performance in the field.

2 Mar 2010

Henry Schein signs strategic partnership to distribute Brain-Pad's NatureZone UV/Ozone oral sanitizer

Henry Schein, Inc., the largest distributor of health care products and services to office-based practitioners, today announced a new strategic partnership with Brain-Pad. Under a new five year agreement, Henry Schein Dental will be the exclusive professional dental distributor in the U.S. and Canada for the NatureZone™ one-touch UV/Ozone oral appliance sanitizer.

26 Feb 2010

Librede to develop technologies for improving ion channel drug discovery and screening at CNSI incubator

Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening.

26 Feb 2010

Nanotechnology to tackle side effects and drug resistance in treatment of cancer

Huixin He, associate professor, nanoscale chemistry at Rutgers University, Newark, and Tamara Minko, professor at the Rutgers Ernest Mario School of Pharmacy, have developed a nanotechnology approach that potentially could eliminate the problems of side effects and drug resistance in the treatment of cancer. Under traditional chemotherapy, cancer cells, like bacteria, can develop resistance to drug therapy, leading to a relapse of the disease.

26 Feb 2010

Ion Torrent to award two Ion Personal Genome Machine sequencers through grant program

Ion Torrent™ today announced that it will award two Ion Personal Genome Machine (PGM™) sequencers in April 2010 through a grant program designed to help make DNA sequencing accessible to all scientists.

24 Feb 2010

New gene locus influencing risk for atrial fibrillation identified

Atrial fibrillation is a cardiac arrhythmia - a chronic irregularity of heartbeat - which affects an estimated 1 million people in Germany. Although the condition is not acutely life-threatening, it does increase the risk of developing more serious illnesses, such as cardiac insufficiency, stroke and dementia. In the third of a series of genomewide asssociation studies, an international team of researchers, led by LMU physician PD Dr. Stefan K--b, now reports the identification of a new gene locus that has a significant influence on risk for atrial fibrillation.

22 Feb 2010

Research paves way for building tabletop X-ray laser that can be used for high-resolution imaging

For nearly half a century, scientists have been trying to figure out how to build a cost-effective and reasonably sized X-ray laser that could, among other things, provide super high-resolution imaging. And for the past two decades, University of Colorado at Boulder physics professors Margaret Murnane and Henry Kapteyn have been inching closer to that goal.

22 Feb 2010

Information on early brain development and the importance of sleep during early life to be presented

Marcos Frank, PhD, associate professor of Neuroscience at the University of Pennsylvania School of Medicine, will present information on early brain development and the importance of sleep during early life when the brain is rapidly maturing and highly changeable.

22 Feb 2010

Mechanosensitive ion channels play a key role in pain sensation

Humans and animals are able to perceive even the slightest vibration and touch of the skin. Mechanosensitive ion channels play a crucial role in the mediation of these sensations. Ion channels are pores in the cell membrane which are highly responsive to external signals.

19 Feb 2010

New research units established for Japanese-German research collaboration

With its ten new Research Units, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is intensifying interdisciplinary and multiple-location collaboration among researchers pursuing specific scientific questions and new avenues of research.

17 Feb 2010

New foundational research may advance pharmacological therapies for neurological disorders

Investigators in the Hotchkiss Brain Institute, Faculty of Medicine, have made a major breakthrough in our understanding of nerve impulse generation within the brain.

17 Feb 2010

CalciMedica granted U.S. composition patent concerning key component of CRAC channel

CalciMedica today announced that the US Patent and Trademark Office has issued to CalciMedica US Patent No. 7,645,588, a composition patent involving STIM1, a key component of the calcium release-activated calcium (CRAC) channel. The patent, entitled "Composition comprising a cell comprising a STIM1 protein and an agent that modulates intracellular calcium and methods of use," has a priority date of March 4, 2003 and was issued on January 12, 2010.

17 Feb 2010

Sustamine L-Alanyl-L-Glutamine supplement increases performance in endurance exercise and activity

A clinical study by Dr. Jay Hoffman, PhD, professor and chair of the Department of Health and Exercise Science at the College of New Jersey, has shown Sustamine™ L-Alanyl-L-Glutamine, increases performance in endurance exercise and activity. The study was published on February 3, 2010, in the Journal of the International Society of Sports Nutrition (JISSN), a peer-reviewed journal covering various aspects of sports nutrition, supplementation, exercise metabolism, and/or scientific policies related to sports nutrition.

12 Feb 2010

Neurotoxin study may help find new therapies to block hyperactive ion channels

There are approximately 500 species of cone snails, each producing 50 - 200 different conotoxins. A similar number of peptide toxins are produced by snakes, spiders, sea anemones, scorpions and other venomous animals. The animals use the neurotoxins to paralyze their prey.

11 Feb 2010

Study validates Transgenomic's COLD-PCR technology for colorectal tumor-associated KRAS mutation detection

Transgenomic, Inc. announced today that it has completed a preliminary study with a leading pharmaceutical company that validates the use of its licensed COLD-PCR technology to detect colorectal tumor-associated KRAS mutations that determine efficacy of recently developed therapies. These were detected in plasma samples in which the mutation levels were too low for detection by standard DNA analysis methodologies such as Sanger sequencing.

9 Feb 2010

Oral care with ionic toothbrush

Smile and the world smiles with you. Well, the folks at Global Ionics LLC, makers of the Ionic ProClean toothbrush, are smiling a lot these days; especially since receiving the impressive results of a clinical evaluation conducted by THE DENTAL ADVISOR. In a clinical assessment, the Ionic ProClean was evaluated by a team of dental professionals and 107 patients in over 11,100 uses. The results? Dental professionals reported that they observed less tartar buildup and gingivitis, and believed the toothbrush contributed to good oral hygiene: earning the Ionic ProClean a 4+ rating from THE DENTAL ADVISOR.

6 Feb 2010

Etch recipe allows engineers and product developers to design diamond devices

Advanced Diamond Technologies (ADT) is making broadly available an etch recipe which enables engineers and product developers to reliably and affordably design micro devices and sensors out of diamond.

4 Feb 2010

Fluxion Biosciences to defend against alleged automated patch clamp system patent infringement lawsuit

Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.

From Fluxion Biosciences 3 Feb 2010

Cellectricon resumes litigation against Fluxion Biosciences over alleged patent infringement

Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.

From Fluxion Biosciences 2 Feb 2010

Florida State University research team to develop way of measuring zinc levels in the human body

A team of Florida State University researchers will use a five-year, $1.3 million grant from the National Institutes of Health to develop a way to measure levels of the trace metal zinc in the human body.

28 Jan 2010

Ion News and Research

Agilent Technologies launches industry’s first transportable GC/MS system delivering laboratory-quality analysis

Henry Schein signs strategic partnership to distribute Brain-Pad's NatureZone UV/Ozone oral sanitizer

Librede to develop technologies for improving ion channel drug discovery and screening at CNSI incubator

Nanotechnology to tackle side effects and drug resistance in treatment of cancer

Ion Torrent to award two Ion Personal Genome Machine sequencers through grant program

New gene locus influencing risk for atrial fibrillation identified

Research paves way for building tabletop X-ray laser that can be used for high-resolution imaging

Information on early brain development and the importance of sleep during early life to be presented

Mechanosensitive ion channels play a key role in pain sensation

New research units established for Japanese-German research collaboration

New foundational research may advance pharmacological therapies for neurological disorders

CalciMedica granted U.S. composition patent concerning key component of CRAC channel

Sustamine L-Alanyl-L-Glutamine supplement increases performance in endurance exercise and activity

Neurotoxin study may help find new therapies to block hyperactive ion channels

Study validates Transgenomic's COLD-PCR technology for colorectal tumor-associated KRAS mutation detection

Oral care with ionic toothbrush

Etch recipe allows engineers and product developers to design diamond devices

Fluxion Biosciences to defend against alleged automated patch clamp system patent infringement lawsuit

Cellectricon resumes litigation against Fluxion Biosciences over alleged patent infringement

Florida State University research team to develop way of measuring zinc levels in the human body

Enhancing confidence in chemical ionization spectrometry data eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News